Rein Therapeutics Inc. (RNTX)
NASDAQ: RNTX · Real-Time Price · USD
0.7250
-0.0234 (-3.13%)
Sep 28, 2026, 3:34 PM EDT - Market open
Rein Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Quarter | Current | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 28, 2026 | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
| 63 | 89 | 36 | 30 | 27 | 31 | 38 | 50 | 77 | 60 | 32 | 15 | 7 | 8 | 6 | 11 | 19 | 24 | 46 | 51 | 92 | |
Market Cap Growth (YoY) | 125.79% | 186.83% | -4.95% | -38.81% | -65.21% | -48.14% | 18.39% | 234.56% | 1011.13% | 635.70% | 475.22% | 38.39% | -63.23% | -65.58% | -87.87% | -78.89% | -79.67% | -79.09% | -64.02% | 20.50% | 80.69% |
Enterprise Value | 22 | 134 | 78 | 71 | 66 | 69 | 66 | 77 | 100 | 94 | 20 | 3 | -7 | -9 | -16 | -15 | -14 | -14 | 1 | -1 | 33 |
Last Close Price | 0.75 | 1.04 | 1.30 | 1.16 | 1.15 | 1.40 | 1.77 | 2.30 | 3.54 | 2.77 | 6.63 | 3.05 | 1.52 | 1.79 | 1.24 | 2.37 | 4.13 | 5.20 | 10.25 | 11.26 | 20.40 |
Price Ratios
Fiscal Quarter | Current | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 28, 2026 | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
PB Ratio | 6.29 | 1.61 | 3.15 | 1.80 | 0.58 | 0.65 | 0.77 | 0.92 | 0.81 | 0.59 | 0.36 | 0.15 | 0.62 | 0.64 | 0.40 | 0.58 | 0.83 | 0.83 | 1.29 | 1.16 | 1.84 |
P/TBV Ratio | - | - | - | - | - | - | - | - | - | - | - | - | 0.62 | 0.64 | 0.40 | 0.58 | 0.83 | 0.83 | 1.29 | 1.16 | 1.84 |
Financial Efficiency
Fiscal Quarter | Current | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 28, 2026 | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Debt / Equity Ratio | - | - | 0.43 | - | - | - | - | - | - | - | - | 0 | - | - | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Debt / Equity Ratio | -0.74 | -0.74 | 0.04 | -0.19 | -0.09 | -0.12 | -0.15 | -0.24 | -0.18 | -0.22 | -0.13 | -0.18 | -1.08 | -1.07 | -1.17 | -1.14 | -1.12 | -1.13 | -1.05 | -1.04 | -1.04 |
Net Debt / EBITDA Ratio | 1.96 | 1.96 | -0.02 | 0.15 | 0.17 | 0.24 | 0.28 | 0.46 | 0.60 | 0.86 | 0.65 | 1.13 | 0.96 | 0.80 | 0.73 | 0.77 | 0.86 | 1.08 | 1.36 | 1.73 | 2.18 |
Net Debt / FCF Ratio | 2.16 | 2.16 | -0.03 | 0.17 | 0.19 | 0.27 | 0.32 | 0.58 | 0.63 | 0.85 | 0.59 | 0.87 | 0.87 | 0.71 | 0.77 | 0.85 | 0.95 | 1.20 | 1.51 | 1.91 | 2.33 |
Quick Ratio | 4.19 | 4.19 | 0.33 | 0.52 | 0.71 | 0.74 | 1.24 | 2.24 | 3.12 | 4.44 | 2.66 | 3.95 | 7.43 | 11.42 | 5.80 | 6.28 | 5.62 | 6.29 | 9.18 | 10.19 | 11.45 |
Current Ratio | 4.27 | 4.27 | 0.40 | 0.70 | 0.90 | 0.86 | 1.39 | 2.38 | 3.30 | 4.69 | 2.82 | 4.17 | 7.88 | 11.66 | 5.93 | 6.46 | 5.96 | 6.51 | 9.65 | 10.69 | 11.94 |
Return on Equity (ROE) | -96.42% | -96.42% | -163.36% | -139.87% | -83.28% | -79.38% | -86.78% | -82.37% | -54.95% | -44.32% | -34.21% | -26.91% | -76.36% | -84.42% | -94.03% | -87.41% | -81.26% | -70.60% | -56.62% | -93.33% | -77.87% |
Return on Assets (ROA) | -21.02% | -21.02% | -32.10% | -31.75% | -18.81% | -18.24% | -21.14% | -20.89% | -31.63% | -25.86% | -19.94% | -14.99% | -39.79% | -45.16% | -50.54% | -49.03% | -45.37% | -39.86% | -33.40% | -51.30% | -38.93% |
Return on Capital Employed (ROCE) | -36.90% | -36.90% | -170.40% | -122.00% | -49.60% | -48.90% | -51.30% | -49.80% | -30.10% | -24.40% | -19.60% | -15.10% | -113.90% | -134.90% | -162.60% | -148.50% | -131.10% | -105.10% | -77.60% | -60.50% | -47.80% |
Yields
Fiscal Quarter | Current | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 28, 2026 | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Sep '25 Sep 30, 2025 | Jun '25 Jun 30, 2025 | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Sep '24 Sep 30, 2024 | Jun '24 Jun 30, 2024 | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Sep '23 Sep 30, 2023 | Jun '23 Jun 30, 2023 | Mar '23 Mar 31, 2023 | Dec '22 Dec 31, 2022 | Sep '22 Sep 30, 2022 | Jun '22 Jun 30, 2022 | Mar '22 Mar 31, 2022 | Dec '21 Dec 31, 2021 | Sep '21 Sep 30, 2021 |
Earnings Yield | -80.11% | -55.94% | -137.74% | -163.55% | -220.67% | -190.72% | -159.77% | -126.19% | -38.13% | -42.17% | -55.77% | -105.62% | -187.47% | -215.05% | -420.63% | -253.93% | -157.57% | -126.69% | -59.49% | -51.32% | -26.38% |
FCF Yield | -30.32% | -21.17% | -45.57% | -63.50% | -78.52% | -68.43% | -60.48% | -44.73% | -36.34% | -42.96% | -63.04% | -132.99% | -200.30% | -235.67% | -385.82% | -231.03% | -142.28% | -114.36% | -54.19% | -46.90% | -24.19% |
Buyback Yield / Dilution | -71.24% | -71.24% | -29.11% | -41.84% | -71.80% | -137.74% | -285.32% | -290.09% | -201.87% | -107.31% | -21.97% | -1.31% | -0.10% | -0.12% | -0.21% | -2.23% | -18.73% | -42.67% | -85.87% | -154.70% | -142.08% |